1. Home
  2. FEIM vs CRVS Comparison

FEIM vs CRVS Comparison

Compare FEIM & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • CRVS
  • Stock Information
  • Founded
  • FEIM 1961
  • CRVS 2014
  • Country
  • FEIM United States
  • CRVS United States
  • Employees
  • FEIM N/A
  • CRVS N/A
  • Industry
  • FEIM Electrical Products
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • CRVS Health Care
  • Exchange
  • FEIM Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • FEIM 173.6M
  • CRVS 206.5M
  • IPO Year
  • FEIM N/A
  • CRVS 2016
  • Fundamental
  • Price
  • FEIM $18.74
  • CRVS $3.63
  • Analyst Decision
  • FEIM
  • CRVS Strong Buy
  • Analyst Count
  • FEIM 0
  • CRVS 3
  • Target Price
  • FEIM N/A
  • CRVS $15.67
  • AVG Volume (30 Days)
  • FEIM 56.1K
  • CRVS 906.6K
  • Earning Date
  • FEIM 03-13-2025
  • CRVS 05-05-2025
  • Dividend Yield
  • FEIM 5.32%
  • CRVS N/A
  • EPS Growth
  • FEIM 604.98
  • CRVS N/A
  • EPS
  • FEIM 2.41
  • CRVS N/A
  • Revenue
  • FEIM $65,400,999.00
  • CRVS N/A
  • Revenue This Year
  • FEIM N/A
  • CRVS N/A
  • Revenue Next Year
  • FEIM N/A
  • CRVS N/A
  • P/E Ratio
  • FEIM $7.61
  • CRVS N/A
  • Revenue Growth
  • FEIM 24.10
  • CRVS N/A
  • 52 Week Low
  • FEIM $8.62
  • CRVS $1.43
  • 52 Week High
  • FEIM $20.33
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 65.94
  • CRVS 55.04
  • Support Level
  • FEIM $17.76
  • CRVS $3.15
  • Resistance Level
  • FEIM $18.65
  • CRVS $3.78
  • Average True Range (ATR)
  • FEIM 0.88
  • CRVS 0.25
  • MACD
  • FEIM 0.23
  • CRVS 0.12
  • Stochastic Oscillator
  • FEIM 94.68
  • CRVS 87.90

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: